Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra's Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
This content is available to members only.
If you are an existing member, please LOGIN
Note a member? Sign up for a FREE account ($89 per month value), and get immediate access. Free offer expires March 15, 2019.
Register New Account
Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2